Tolerogenic vaccination with MOG/VitD overcomes aggravating effect of C. albicans in experimental encephalomyelitis

Tolerogenic vaccination with MOG/VitD overcomes aggravating effect of C. albicans in experimental encephalomyelitis

Thais F.C. Fraga-Silva, Luiza A.N. Mimura, Sofia F.G. Zorzella-Pezavento, Larissa L.W. Ishikawa, Thais G.D. França, Rodolfo Thomé, Liana Verinaud, Maria S.P. Arruda, Alexandrina Sartori

ARTIGO

Inglês

Multiple sclerosis (MS) is an immune‐mediated demyelinating disorder of the central nervous system (CNS). We described that Candida albicans (Ca) aggravates experimental autoimmune encephalomyelitis (EAE) that is a model to study MS. We also observed that vaccination with a myelin peptide (MOG) in...

FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESP

2012/12540-7; 2013/14353-2

Fechado

Tolerogenic vaccination with MOG/VitD overcomes aggravating effect of C. albicans in experimental encephalomyelitis

Thais F.C. Fraga-Silva, Luiza A.N. Mimura, Sofia F.G. Zorzella-Pezavento, Larissa L.W. Ishikawa, Thais G.D. França, Rodolfo Thomé, Liana Verinaud, Maria S.P. Arruda, Alexandrina Sartori

										

Tolerogenic vaccination with MOG/VitD overcomes aggravating effect of C. albicans in experimental encephalomyelitis

Thais F.C. Fraga-Silva, Luiza A.N. Mimura, Sofia F.G. Zorzella-Pezavento, Larissa L.W. Ishikawa, Thais G.D. França, Rodolfo Thomé, Liana Verinaud, Maria S.P. Arruda, Alexandrina Sartori

    Fontes

    CNS neuroscience & therapeutics

    Vol. 22, no. 10 (Oct., 2016), p. 807-816